Advertisement

International Journal of Hematology

, Volume 79, Issue 1, pp 48–51 | Cite as

Acute Spontaneous Tumor Lysis in Anaplastic Large T-Cell Lymphoma Presenting with Hyperuricemic Acute Renal Failure

Case Report

Abstract

Acute spontaneous tumor lysis (ASTL) syndrome, an extremely rare disease, requires prompt recognition and aggressive management because it is fulminant at its outset, associated with severe metabolic derangement, and potentially reversible. We describe an unusual case in which spontaneous tumor lysis occurred in anaplastic large T-cell lymphoma associated with acute uric acid nephropathy, persistent oliguria, and shock. This case contrasts markedly with previously reported cases of ASTL syndrome, which developed mainly in the pathologic type of Burkitt lymphoma. To our knowledge, this is the first reported occurrence of ASTL syndrome associated with anaplastic large T-cell type lymphoma. This report also chronicles our successful experience with continuous renal replacement therapy in the presence of compromised hemodynamic status.

Key words

Acute spontaneous tumor lysis syndrome Acute uric acid nephropathy Continuous venovenous hemodialysis Malignant lymphoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine.Am J Pathol. 1992;141:1361–1371.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center.J Clin Oncol. 2000;18:795–803.CrossRefGoogle Scholar
  3. 3.
    Isaacson PG. The current status of lymphoma classification.Br J Haematol. 2000;109:258–266.CrossRefGoogle Scholar
  4. 4.
    Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograft rejection.Immunity. 2001;14:377–386.CrossRefGoogle Scholar
  5. 5.
    Nagira M, Imai T, Hieshima K, et al. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemokine chemoattractant for lymphocytes and mapped to chromosome 9p13.J Biol Chem. 1997;272:19518–19524.CrossRefGoogle Scholar
  6. 6.
    Yoshida R, Imai T, Hieshima K, et al. Molecular cloning of a novel human CC chemokine EBI1 ligand chemokine that is a specific functional ligand for EBI1, CCR7.J Biol Chem. 1997;272:13803–13809.CrossRefGoogle Scholar
  7. 7.
    Fleming MD, Pinkus JL, Alexander SW, et al. Coincidental expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis.Blood. 2003;101:2473–2475.CrossRefGoogle Scholar
  8. 8.
    Agace WW, Roberts AI, Wu L, Greineder C, Ebert EC, Parker CM. Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation.Eur J Immunol. 2000;30:819–826.CrossRefGoogle Scholar
  9. 9.
    Forester R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.Cell. 1999;99:23–33.CrossRefGoogle Scholar
  10. 10.
    Hasegawa H, Nomura T, Kohno M, et al. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.Blood. 2000;95:30–38.Google Scholar
  11. 11.
    Till KJ, Lin K, Zuzel M, Cawley JC. The chemokine receptor CCR7 and α4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.Blood. 2002;99:2977–2984.CrossRefGoogle Scholar
  12. 12.
    Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.Nature. 1999;401:708–712.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2004

Authors and Affiliations

  1. 1.Department of NephrologyChang Gung Memorial HospitalKweishanTaiwan

Personalised recommendations